Cellcept /01275102/


Combined with:

Prograf

Indications and Reactions:

Role Indications Reactions
Secondary
Renal Transplant 27.6%
Product Used For Unknown Indication 23.5%
Immunosuppressant Drug Therapy 9.0%
Liver Transplant 4.9%
Hypertension 3.4%
Immunosuppression 3.4%
Premedication 3.4%
Prophylaxis Against Graft Versus Host Disease 3.4%
Prophylaxis Against Transplant Rejection 3.0%
Graft Versus Host Disease 2.6%
Gastrointestinal Hypomotility 2.2%
Viral Infection 2.2%
Hyperlipidaemia 1.9%
Hypothyroidism 1.9%
Prophylaxis 1.9%
Bone Marrow Transplant 1.5%
Dyslipidaemia 1.1%
Epilepsy 1.1%
Prophylaxis Against Gastrointestinal Ulcer 1.1%
Pyrexia 1.1%
Gastritis Haemorrhagic 12.2%
Myelitis Transverse 7.3%
Renal Impairment 7.3%
Gastroenteritis 4.9%
Hypertension 4.9%
Kidney Fibrosis 4.9%
Kidney Transplant Rejection 4.9%
Neutropenia 4.9%
Overdose 4.9%
Renal Failure 4.9%
Renal Failure Acute 4.9%
Testicular Germ Cell Cancer 4.9%
Toxicity To Various Agents 4.9%
Transplant Failure 4.9%
Urinary Tract Infection Bacterial 4.9%
Urosepsis 4.9%
Adenocarcinoma Pancreas 2.4%
Bone Marrow Toxicity 2.4%
Breast Cancer 2.4%
Eosinophilia 2.4%
Concomitant
Product Used For Unknown Indication 49.5%
Renal Transplant 14.0%
Immunosuppressant Drug Therapy 6.3%
Hypertension 5.7%
Liver Transplant 4.2%
Immunosuppression 3.9%
Prophylaxis Against Transplant Rejection 2.8%
Heart Transplant 2.3%
Prophylaxis 2.2%
Graft Versus Host Disease 1.2%
Anaemia 1.0%
Premedication 0.9%
Diabetes Mellitus 0.8%
Pancreas Transplant 0.8%
Prophylaxis Against Graft Versus Host Disease 0.8%
Vitamin Supplementation 0.8%
Gastroenteritis 0.7%
Infection Prophylaxis 0.7%
Type 2 Diabetes Mellitus 0.7%
Ascites 0.7%
Death 17.8%
Off Label Use 8.5%
Vomiting 7.6%
Renal Failure Acute 6.8%
Transplant Rejection 6.8%
Renal Disorder 5.9%
Sepsis 5.1%
Tremor 5.1%
Toxicity To Various Agents 4.2%
Urinary Tract Infection 4.2%
Lipase Increased 3.4%
Pyrexia 3.4%
Renal Transplant 3.4%
Infection 2.5%
Pruritus 2.5%
Renal Failure Chronic 2.5%
Renal Impairment 2.5%
Treatment Noncompliance 2.5%
Venoocclusive Liver Disease 2.5%
Visual Impairment 2.5%

Drug Data